Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9375 USD | -1.15% | -4.34% | -46.12% |
Evolution of the average Target Price on Sonnet BioTherapeutics Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sonnet BioTherapeutics Holdings, Inc.
Chardan Research | |
Ladenburg Thalmann | |
EF Hutton | |
BTIG | |
Chardan | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- SONN Stock
- Consensus Sonnet BioTherapeutics Holdings, Inc.